Mykor announced a £4 million funding round led by Clean Growth Fund and The FSE Group, bringing the company’s total funding raised to £7.5 million. The investment will support the continued development and commercialization of the company’s biotechnology platform, which converts industrial and agricultural waste streams into low-carbon construction materials designed to help decarbonize the built environment.
The company is tackling one of the construction sector’s most pressing challenges: reducing carbon emissions while maintaining the levels of fire safety, durability, affordability, and performance required for large-scale adoption. As governments, developers, and manufacturers face increasing pressure to meet sustainability targets, demand is growing for alternative building materials that can lower embodied carbon without disrupting existing construction practices.
Mykor’s platform combines proprietary engineered mycelium strains, green chemistry additives, and closed-loop biofabrication processes to create a new generation of construction products. These products include prefabricated wall systems, cavity wall insulation, and other building materials that are designed to replace or supplement conventional carbon-intensive alternatives. By utilizing agricultural and industrial byproducts as feedstocks, the company aims to reduce waste while creating commercially viable materials for the construction industry.
Rather than operating as a single-product manufacturer, Mykor positions itself as a scalable technology platform. Its approach enables contractors, manufacturers, and construction partners to integrate biomaterials into existing supply chains, production facilities, and building systems without requiring significant operational changes. This platform-based strategy is intended to accelerate adoption across multiple segments of the construction market while allowing partners to leverage Mykor’s biotechnology and manufacturing processes.
The company believes its technology can play a meaningful role in reducing the environmental impact of construction, which remains one of the largest contributors to global carbon emissions. By combining biological manufacturing techniques with industrial-scale production methods, Mykor seeks to provide sustainable alternatives that can compete on performance, safety, and cost.
Alongside the funding announcement, Mykor revealed that it has secured more than £338 million in commercial agreements across the UK and Europe. These agreements span a range of construction and development projects and reflect growing interest in low-carbon building materials among both public- and private-sector customers. The company plans to use the new capital to expand production capabilities, advance product development, strengthen commercial partnerships, and accelerate its expansion across key European markets as demand for sustainable construction solutions continues to increase.
